Beyond resistance: Making prescription drugs more affordable

July 30, 2017
Enewsletter

Dear Friends,

It is the second day of my email series, “Beyond Resistance: The things we should do to make us safer, healthier, and more economically secure.” Today’s topic: the urgent need to make prescription drugs more affordable.

Drug companies have been taking advantage of Americans for too long. As drug prices have risen at an alarming rate, we need to protect the affordability of necessary medical treatments. New drugs for cancer and rare diseases can cost more than $100,000 a year, causing many to choose between their health or their family’s financial security. Even generic medicines for chronic conditions, such as insulin, have seen prices triple or more between 2002-2013. 

Big Pharma continues to get rich while Americans are being gouged.

The U.S. Department of Veterans Affairs is currently the only agency that is allowed to use the power of the federal government to negotiate with pharmaceutical companies. We must also allow Medicare and Medicaid to negotiate drug prices to get a better deal on behalf of patients. I am a strong supporter of the Medicare Prescription Drug Price Negotiation Act, which would legalize these negotiations and lower drug prices for Medicare and Medicaid patients. 

I welcome your thoughts, ideas, and opinions. You can connect with me here.

Courage,

Earl Blumenauer
Member of Congress